Artikel (Klinikum der LMU)

Mönch, Sebastian; Heimer, Maurice M.; Winkelmann, Michael; Guertler, Anne; Schlaak, Max; Tufman, Amanda; Ben Khaled, Najib; de Toni, Enrico; Westphalen, Christoph B.; von Bergwelt-Baildon, Michael; Dinkel, Julien; Kazmierczak, Philipp M.; Ingrisch, Michael; Mansour, Nabeel; Unterrainer, Marcus; Heinzerling, Lucie; Ricke, Jens; Kunz, Wolfgang G. (2023): Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors. Cancer Imaging, 23 (1). ISSN 1470-7330

Winkelmann, Michael; Blumenberg, Viktoria; Rejeski, Kai; Bücklein, Veit L.; Ingenerf, Maria; Unterrainer, Marcus; Schmidt, Christian; Dekorsy, Franziska J.; Bartenstein, Peter; Ricke, Jens; von Bergwelt-Baildon, Michael; Subklewe, Marion; Kunz, Wolfgang G. (2023): Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria. Cancer Imaging, 23 (1). ISSN 1470-7330

Eschbach, Ralf S.; Hofmann, Markus; Späth, Lukas; Sheikh, Gabriel T.; Delker, Astrid; Lindner, Simon; Jurkschat, Klaus; Wängler, Carmen; Wängler, Björn; Schirrmacher, Ralf; Tiling, Reinhold; Brendel, Matthias; Wenter, Vera; Dekorsy, Franziska J.; Zacherl, Mathias J.; Todica, Andrei; Ilhan, Harun; Grawe, Freba; Cyran, Clemens C.; Unterrainer, Marcus; Rübenthaler, Johannes; Knösel, Thomas; Paul, Tanja; Boeck, Stefan; Westphalen, Christoph Benedikt; Spitzweg, Christine; Auernhammer, Christoph J.; Bartenstein, Peter; Unterrainer, Lena M.; Beyer, Leonie (2023): Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE. Frontiers in Oncology, 13. ISSN 2234-943X

Winkelmann, Michael; Bücklein, Veit L.; Blumenberg, Viktoria; Rejeski, Kai; Ruzicka, Michael; Unterrainer, Marcus; Schmidt, Christian; Dekorsy, Franziska J.; Bartenstein, Peter; Ricke, Jens; von Bergwelt-Baildon, Michael; Subklewe, Marion; Kunz, Wolfgang G. (2022): Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessment. Frontiers in Oncology, 12. ISSN 2234-943X